Old Web
English
Sign In
Acemap
>
authorDetail
>
Daniel Ness
Daniel Ness
MorphoSys
Cytotoxicity
In vitro
Antibody
Cancer research
Lymphoma
3
Papers
20
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The Combination of Tafasitamab and Rituximab Increases Cytotoxicity Against Lymphoma Cells In Vitro
2020
Blood
Maria Patra
Christian Augsberger
Carmen Ginzel
Andrea Polzer
Karin Landgraf
Dominik Bartel
Daniel Ness
Stefan Steidl
Christina Heitmüller
Juergen Schanzer
Jan Endell
Show All
Source
Cite
Save
Citations (0)
Evaluation of combination therapies with MOR00208, an Fc-enhanced humanized CD19 antibody, in models of lymphoma.
2017
Journal of Clinical Oncology
Mark Winderlich
Daniel Ness
Stefan Steidl
Jan Endell
Show All
Source
Cite
Save
Citations (2)
The Activity of MOR202, a Fully Human Anti-CD38 Antibody, Is Complemented by ADCP and Is Synergistically Enhanced by Lenalidomide in Vitro and in Vivo
2012
Blood
Jan Endell
Rainer Boxhammer
Cornelia Wurzenberger
Daniel Ness
Stefan Steidl
Show All
Source
Cite
Save
Citations (18)
1